CIK 0001829635 · <br>Emerging growth company
Transcode Therapeutics, Inc.
Sign in to watch- Ticker
- RNAZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811065054
- Phone
- 857-301-6857
- Business address
- 6 LIBERTY SQUARE, #2382, BOSTON, MA, 02109
- 8-K Event Delisting notice
- 4 Insider Changes in Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 4/A Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Material agreement · Delisting notice · Other events
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Executive or director change
Page 11 of 17 · 324 filings